Home/ Supplements/ Black Cohosh/ Estro-Mend

Estro-Mend

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Estro-Mend
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Isoflavone Complex Herbal Proprietary Blend
375 mg
60 mg
Market median: 80.0mg (136 products)
Estromend Herbal Proprietary Blend
1185 mg

Other Ingredients

Gelatin Dicalcium Phosphate Cellulose Vegetable Stearate Vegetable Stearate Vegetable Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 3 capsules daily with food or as directed by your healthcare professional..

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

WARNING: Not to be used by pregnant or nursing women.

Tamper resistant package, do not use if outer seal is missing.

Formulation Notes

This product contains NO yeast, gluten, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #99260

Metadata

Product Details

UPC / SKU3 10539 02259 7
DSLD Entry Date2012-03-23
Product TypeOther Combinations
FormCapsule
DSLD ID6658
Data Updated2026-04-11
Research

Research Evidence

31
Research Sources
49
Avg Quality
23
Systematic Review
5
Meta Analysis
1
Rct
1
Openfda Safety
B [Efficacy of black cohosh extracts for improving low estrogen status induced by postoperative GnRHa treatment in patients with endometriosis: a systematic review]
Systematic Review Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2020 PubMed
B Black cohosh (Cimicifuga spp.) for menopausal symptoms
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Systematic Review BJOG : an international journal of obstetrics and gynaecology 2017 PubMed DOI
C Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract
Meta Analysis Menopause (New York, N.Y.) 2011 PubMed DOI
C Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
Meta Analysis Climacteric : the journal of the International Menopause Society 2021 PubMed DOI
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2007 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2011 PubMed
C Menopausal symptoms
Systematic Review BMJ clinical evidence 2010 PubMed
C Black cohosh extracts in women with menopausal symptoms: an updated pairwise meta-analysis
Meta Analysis Menopause (New York, N.Y.) 2023 PubMed DOI
C Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis
Meta Analysis Alternative therapies in health and medicine 2010 PubMed
View all evidence for Black Cohosh →
Compare

Similar Products

View all Black Cohosh products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.